NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome

摘要

The use of known NK-1 receptor antagonists of the formula 1, II or III according to US 3560510, US 4358446 and many others according to page 1a of the disclosure for the treatment of irritable bowel syndrome particularly abdominal pain.